Everspin Technologies, Inc. stands as the leading developer and manufacturer of magnetoresistive random access memory (MRAM), a persistent, non-volatile memory technology that holds data even without power. Based in Chandler, Arizona, the company offers Toggle MRAM and spin-transfer torque (STT-MRAM) products along with tunnel magnetoresistance (TMR) sensors. These serve industrial, medical, automotive, aerospace and defense, and data center markets. Revenue comes from direct sales, distribution, licensing, royalties, and engineering services, including U.S. defense work. I find MRAM noteworthy because its technology aligns with high-reliability memory needs, edge AI applications, and domestic semiconductor initiatives.
Over the last 30 days, MRAM declined approximately 31.8%, moving from a September 25, 2026, close of $18.47 down to $12.59 on October 23, 2026. The stock hit an intraday high near $19.77 early in October before sliding to a monthly low around $12.22. The drop unfolded gradually across multiple sessions rather than in one sharp move.
Over the full quarter, the stock is off roughly 24% from levels near $16.60 in late July. The period featured an initial rally into late September and early October, followed by a sharp reversal that erased those gains. This pattern shows how strong fundamentals can still face near-term pressure from shifting sector sentiment.
The drop happened without negative company-specific news or any analyst downgrades. Instead, it reflected broader market dynamics. A wide semiconductor and AI-hardware selloff hit small-cap names hard, with MRAM falling more than 7% in one session alongside peers. Profit-taking also played a role after the stock had gained more than 40% year to date at its peak. Positioning ahead of the third-quarter earnings report on October 28 added to caution in this high-beta name. Analyst views stayed positive, with Maxim Group starting coverage at Buy and a $25 target while Needham held its Buy rating and $19 target. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The quarter featured solid execution despite market challenges. Everspin posted record second-quarter 2026 revenue of $18.7 million, up 42% year over year, and non-GAAP earnings of $0.11 per diluted share, both beating guidance. Growth came from MRAM product sales plus initial revenue from a two-and-a-half-year, $40 million subcontract with a U.S. prime contractor and a manufacturing agreement with Microchip Technology to boost onshore capacity. Other positives included a design win for a geosynchronous-Earth-orbit satellite mission with Astro Digital and the first demonstration of a Compute Express Link (CXL)-connected MRAM platform. The later reversal stemmed from sector-wide risk aversion rather than any shift in the company’s trajectory.
Several items merit attention going forward. The third-quarter 2026 earnings release on October 28 will serve as a key catalyst, with guidance for revenue of $19.5 million to $20.5 million and non-GAAP earnings of $0.10 to $0.15 per diluted share. Revenue timing under the $40 million defense subcontract, which management has noted will not follow a straight line, is worth tracking. Product gross margins face pressure from packaging and assembly costs, and the status of the Chandler fabrication facility after its planned sale by NXP Semiconductors remains relevant. Broader semiconductor sentiment, demand in industrial, aerospace and defense, and data center markets, plus adoption of the higher-density MRAM roadmap, will also influence the outlook.
In my own review process, I often turn to Tickeron’s AI Trading Bots to test automated strategies across a wide range of tickers and timeframes. The platform lets users compare performance metrics and approaches that align with different risk profiles and objectives, providing a practical way to evaluate systematic ideas alongside traditional analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MRAM declined for three days, in 218 of 293 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRAM as a result. In 57 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for MRAM turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 32 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
MRAM moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRAM crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
The 50-day moving average for MRAM moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Aroon Indicator for MRAM entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRAM advanced for three days, in 220 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
MRAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.193) is normal, around the industry mean (6.022). P/E Ratio (-104.917) is within average values for comparable stocks, (20.769). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (5.328) is also within normal values, averaging (45.794).
The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. MRAM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of magnetic random access memory chips
Industry Semiconductors